Targeting FOXM1 regulates metabolic signatures through ROS-dependent JNK/Bmi1/Skp2 axis in human cutaneous T-cell lymphoma. The gene discussed is SKP2; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.